首页 > 最新文献

American Journal of Chinese Medicine最新文献

英文 中文
Efficacy and Safety of Glycyrrhizic Acid in Treatment of Autoimmune Hepatitis. 甘草酸治疗自身免疫性肝炎的疗效和安全性。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500209
Xiaoyue Bi, Liu Yang, Yanjie Lin, Wen Deng, Tingting Jiang, Lu Zhang, Yao Lu, Wei Yi, Yao Xie, Minghui Li
To compare the long-term efficacy and safety of glycyrrhizic acid preparation and hormone treatment in patients with autoimmune hepatitis, we enrolled 377 patients in a study that lasted from January 2009 to January 2020. After performing propensity score matching, we included 58 patients in the hormone group and 58 in the glycyrrhizic acid preparation group in statistical analysis. We then compared the ratio of sustained biochemical responses at 48 weeks after treatment. Adverse events, including some incidence of decompensated liver cirrhosis and liver cancer, were evaluated. The results showed that a total of 61.8% of treated patients achieved complete biochemical remission. The cumulative biochemical remission rate in the hormone group and glycyrrhizic acid preparation group showed no significant difference (62.3% vs. 60.7%, [Formula: see text], [Formula: see text]). At the end of follow-up, the total bile acid in the hormone group was significantly higher than that in the glycyrrhizic acid preparation group (8.9[Formula: see text][Formula: see text]mol/L vs. 5.6[Formula: see text][Formula: see text]mol/L, [Formula: see text], [Formula: see text]). The incidence of adverse reactions in the hormone group was significantly higher than that in the glycyrrhizic acid preparation group (31.03% vs. 15.52%, [Formula: see text], [Formula: see text]). In conclusion, compared with the hormone treatment, glycyrrhizic acid preparation might be a safe and effective treatment for autoimmune hepatitis.
为了比较甘草酸制剂和激素治疗对自身免疫性肝炎患者的长期疗效和安全性,我们在2009年1月至2020年1月期间招募了377名患者。经倾向评分匹配后,我们将58例患者分为激素组和58例甘草酸制剂组进行统计分析。然后我们比较了治疗后48周持续生化反应的比例。不良事件,包括一些失代偿性肝硬化和肝癌的发生率进行了评估。结果显示,61.8%的治疗患者达到完全生化缓解。激素组和甘草酸制剂组的累积生化缓解率差异无统计学意义(62.3% vs. 60.7%,[公式:见文],[公式:见文])。随访结束时,激素组总胆汁酸显著高于甘草酸制剂组(8.9[公式:见文][公式:见文]mol/L vs. 5.6[公式:见文][公式:见文][公式:见文],[公式:见文],[公式:见文])。激素组不良反应发生率明显高于甘草酸制剂组(31.03% vs. 15.52%,[公式:见文],[公式:见文])。综上所述,与激素治疗相比,甘草酸制剂可能是一种安全有效的自身免疫性肝炎治疗方法。
{"title":"Efficacy and Safety of Glycyrrhizic Acid in Treatment of Autoimmune Hepatitis.","authors":"Xiaoyue Bi, Liu Yang, Yanjie Lin, Wen Deng, Tingting Jiang, Lu Zhang, Yao Lu, Wei Yi, Yao Xie, Minghui Li","doi":"10.1142/S0192415X23500209","DOIUrl":"https://doi.org/10.1142/S0192415X23500209","url":null,"abstract":"To compare the long-term efficacy and safety of glycyrrhizic acid preparation and hormone treatment in patients with autoimmune hepatitis, we enrolled 377 patients in a study that lasted from January 2009 to January 2020. After performing propensity score matching, we included 58 patients in the hormone group and 58 in the glycyrrhizic acid preparation group in statistical analysis. We then compared the ratio of sustained biochemical responses at 48 weeks after treatment. Adverse events, including some incidence of decompensated liver cirrhosis and liver cancer, were evaluated. The results showed that a total of 61.8% of treated patients achieved complete biochemical remission. The cumulative biochemical remission rate in the hormone group and glycyrrhizic acid preparation group showed no significant difference (62.3% vs. 60.7%, [Formula: see text], [Formula: see text]). At the end of follow-up, the total bile acid in the hormone group was significantly higher than that in the glycyrrhizic acid preparation group (8.9[Formula: see text][Formula: see text]mol/L vs. 5.6[Formula: see text][Formula: see text]mol/L, [Formula: see text], [Formula: see text]). The incidence of adverse reactions in the hormone group was significantly higher than that in the glycyrrhizic acid preparation group (31.03% vs. 15.52%, [Formula: see text], [Formula: see text]). In conclusion, compared with the hormone treatment, glycyrrhizic acid preparation might be a safe and effective treatment for autoimmune hepatitis.","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 2","pages":"391-405"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9563101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Paeoniflorin Coordinates Macrophage Polarization and Mitigates Liver Inflammation and Fibrogenesis by Targeting the NF-[Formula: see text]B/HIF-1α Pathway in CCl4-Induced Liver Fibrosis. 在ccl4诱导的肝纤维化中,芍药苷通过NF- B/HIF-1α通路调节巨噬细胞极化,减轻肝脏炎症和纤维化。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X2350057X
Yang Liu, Chun-Yu He, Xue-Mei Yang, Wei-Cong Chen, Ming-Jia Zhang, Xiao-Dan Zhong, Wei-Guang Chen, Bing-Lian Zhong, Song-Qi He, Hai-Tao Sun

Liver fibrosis is a disease largely driven by resident and recruited macrophages. The phenotypic switch of hepatic macrophages can be achieved by chemo-attractants and cytokines. During a screening of plants traditionally used to treat liver diseases in China, paeoniflorin was identified as a potential drug that affects the polarization of macrophages. The aim of this study was to evaluate the therapeutic effects of paeoniflorin in an animal model of liver fibrosis and explore its underlying mechanisms. Liver fibrosis was induced in Wistar rats via an intraperitoneal injection of CCl4. In addition, the RAW264.7 macrophages were cultured in the presence of CoCl2 to simulate a hypoxic microenvironment of fibrotic livers in vitro. The modeled rats were treated daily with either paeoniflorin (100, 150, and 200[Formula: see text]mg/kg) or YC-1 (2[Formula: see text]mg/kg) for 8 weeks. Hepatic function, inflammation and fibrosis, activation of hepatic stellate cells (HSC), and extracellular matrix (ECM) deposition were assessed in the in vivo and in vitro models. The expression levels of M1 and M2 macrophage markers and the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway factors were measured using standard assays. Paeoniflorin significantly alleviated hepatic inflammation and fibrosis, as well as hepatocyte necrosis in the CCl4-induced fibrosis model. Furthermore, paeoniflorin also inhibited HSC activation and reduced ECM deposition both in vivo and in vitro. Mechanistically, paeoniflorin restrained M1 macrophage polarization and induced M2 polarization in the fibrotic liver tissues as well as in the RAW264.7 cells grown under hypoxic conditions by inactivating the NF-[Formula: see text]B/HIF-1[Formula: see text] signaling pathway. In conclusion, paeoniflorin exerts its anti-inflammatory and anti-fibrotic effects in the liver by coordinating macrophage polarization through the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway.

肝纤维化是一种主要由常驻和募集的巨噬细胞驱动的疾病。肝巨噬细胞的表型转换可以通过化学引诱剂和细胞因子来实现。在筛选中国传统的用于治疗肝脏疾病的植物时,芍药苷被确定为一种影响巨噬细胞极化的潜在药物。本研究旨在评价芍药苷对肝纤维化动物模型的治疗作用,并探讨其作用机制。腹腔注射CCl4诱导Wistar大鼠肝纤维化。此外,在CoCl2存在下培养RAW264.7巨噬细胞,模拟体外纤维化肝脏的缺氧微环境。造模大鼠每天给予芍药苷(100、150和200[公式:见文]mg/kg)或YC-1(2[公式:见文]mg/kg) 8周。在体内和体外模型中评估肝功能、炎症和纤维化、肝星状细胞(HSC)活化和细胞外基质(ECM)沉积。采用标准法测定巨噬细胞M1、M2标记物及NF-[公式:见文]B/HIF-1通路因子的表达水平。芍药苷可显著减轻ccl4诱导的肝纤维化模型的肝脏炎症和纤维化,以及肝细胞坏死。此外,芍药苷在体内和体外均能抑制HSC的活化,减少ECM的沉积。在机制上,芍药苷通过灭活NF-[公式:见文]B/HIF-1[公式:见文]信号通路,抑制纤维化肝组织和缺氧条件下生长的RAW264.7细胞中的M1巨噬细胞极化,诱导M2极化。综上所述,芍药苷在肝脏中发挥抗炎抗纤维化作用是通过NF-[公式:见文]B/HIF-1[公式:见文]通路协调巨噬细胞极化。
{"title":"Paeoniflorin Coordinates Macrophage Polarization and Mitigates Liver Inflammation and Fibrogenesis by Targeting the NF-[Formula: see text]B/HIF-1α Pathway in CCl<sub>4</sub>-Induced Liver Fibrosis.","authors":"Yang Liu,&nbsp;Chun-Yu He,&nbsp;Xue-Mei Yang,&nbsp;Wei-Cong Chen,&nbsp;Ming-Jia Zhang,&nbsp;Xiao-Dan Zhong,&nbsp;Wei-Guang Chen,&nbsp;Bing-Lian Zhong,&nbsp;Song-Qi He,&nbsp;Hai-Tao Sun","doi":"10.1142/S0192415X2350057X","DOIUrl":"https://doi.org/10.1142/S0192415X2350057X","url":null,"abstract":"<p><p>Liver fibrosis is a disease largely driven by resident and recruited macrophages. The phenotypic switch of hepatic macrophages can be achieved by chemo-attractants and cytokines. During a screening of plants traditionally used to treat liver diseases in China, paeoniflorin was identified as a potential drug that affects the polarization of macrophages. The aim of this study was to evaluate the therapeutic effects of paeoniflorin in an animal model of liver fibrosis and explore its underlying mechanisms. Liver fibrosis was induced in Wistar rats via an intraperitoneal injection of CCl<sub>4</sub>. In addition, the RAW264.7 macrophages were cultured in the presence of CoCl<sub>2</sub> to simulate a hypoxic microenvironment of fibrotic livers <i>in vitro</i>. The modeled rats were treated daily with either paeoniflorin (100, 150, and 200[Formula: see text]mg/kg) or YC-1 (2[Formula: see text]mg/kg) for 8 weeks. Hepatic function, inflammation and fibrosis, activation of hepatic stellate cells (HSC), and extracellular matrix (ECM) deposition were assessed in the <i>in vivo</i> and <i>in vitro</i> models. The expression levels of M1 and M2 macrophage markers and the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway factors were measured using standard assays. Paeoniflorin significantly alleviated hepatic inflammation and fibrosis, as well as hepatocyte necrosis in the CCl<sub>4</sub>-induced fibrosis model. Furthermore, paeoniflorin also inhibited HSC activation and reduced ECM deposition both <i>in vivo</i> and <i>in vitro</i>. Mechanistically, paeoniflorin restrained M1 macrophage polarization and induced M2 polarization in the fibrotic liver tissues as well as in the RAW264.7 cells grown under hypoxic conditions by inactivating the NF-[Formula: see text]B/HIF-1[Formula: see text] signaling pathway. In conclusion, paeoniflorin exerts its anti-inflammatory and anti-fibrotic effects in the liver by coordinating macrophage polarization through the NF-[Formula: see text]B/HIF-1[Formula: see text] pathway.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 5","pages":"1249-1267"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9852498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/ATR Pathway in Androgen-Independent Prostate Cancer. 维拉拉敏通过ATM/ATR途径抑制癌症雄激素依赖性前列腺癌细胞周期的进展、迁移和侵袭。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 Epub Date: 2023-06-30 DOI: 10.1142/S0192415X2350060X
Hee-Yeon Kim, Seoung-Woo Lee, Seong-Kyoon Choi, Janbolat Ashim, Wansoo Kim, Su-Min Beak, Jin-Kyu Park, Jee Eun Han, Gil-Jae Cho, Zae Young Ryoo, Jain Jeong, Yong-Ho Lee, Hyohoon Jeong, Wookyung Yu, Song Park

Prostate cancer (PC) is the second leading cause of cancer-related death among men. Treatment of PC becomes difficult after progression because PC that used to be androgen-dependent becomes androgen-independent prostate cancer (AIPC). Veratramine, an alkaloid extracted from the root of the Veratrum genus, has recently been reported to have anticancer effects that work against various cancers; however, its anticancer effects and the underlying mechanism of action in PC remain unknown. We investigated the anticancer effects of veratramine on AIPC using PC3 and DU145 cell lines, as well as a xenograft mouse model. The antitumor effects of veratramine were evaluated using the CCK-8, anchorage-independent colony formation, trans-well, wound healing assays, and flow cytometry in AIPC cell lines. Microarray and proteomics analyses were performed to investigate the differentially expressed genes and proteins induced by veratramine in AIPC cells. A xenograft mouse model was used to confirm the therapeutic response and in vivo efficacy of veratramine. Veratramine dose dependently reduced the proliferation of cancer cells both in vitro and in vivo. Moreover, veratramine treatment effectively suppressed the migration and invasion of PC cells. The immunoblot analysis revealed that veratramine significantly downregulated Cdk4/6 and cyclin D1 via the ATM/ATR and Akt pathways, both of which induce a DNA damage response that eventually leads to G1 phase arrest. In this study, we discovered that veratramine exerted antitumor effects on AIPC cells. We demonstrated that veratramine significantly inhibited the proliferation of cancer cells via G0/G1 phase arrest induced by the ATM/ATR and Akt pathways. These results suggest that veratramine is a promising natural therapeutic agent for AIPC.

前列腺癌症(PC)是男性癌症相关死亡的第二大原因。PC的治疗在进展后变得困难,因为PC过去是雄激素依赖性的,变成了雄激素非依赖性的癌症(AIPC)。Veratramine是一种从Veratrum属植物的根中提取的生物碱,最近被报道具有抗癌作用,可以对抗各种癌症;然而,它的抗癌作用和在PC中的潜在作用机制仍然未知。我们使用PC3和DU145细胞系以及异种移植小鼠模型研究了维拉曲明对AIPC的抗癌作用。在AIPC细胞系中,使用CCK-8、锚定非依赖性集落形成、反式阱、伤口愈合测定和流式细胞术来评估维拉曲明的抗肿瘤作用。采用微阵列和蛋白质组学方法研究维拉曲明诱导AIPC细胞差异表达的基因和蛋白质。使用异种移植物小鼠模型来证实维拉曲明的治疗反应和体内疗效。维拉曲明在体内外均能剂量依赖性地抑制癌症细胞的增殖。此外,维拉曲明处理能有效抑制PC细胞的迁移和侵袭。免疫印迹分析显示,维拉曲明通过ATM/ATR和Akt途径显著下调Cdk4/6和细胞周期蛋白D1,这两种途径都诱导DNA损伤反应,最终导致G1期阻滞。在本研究中,我们发现维拉曲明对AIPC细胞具有抗肿瘤作用。我们证明,维拉曲明通过ATM/ATR和Akt途径诱导的G0/G1期阻滞显著抑制癌症细胞的增殖。这些结果表明,维拉曲明是一种很有前途的AIPC天然治疗剂。
{"title":"Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM/ATR Pathway in Androgen-Independent Prostate Cancer.","authors":"Hee-Yeon Kim,&nbsp;Seoung-Woo Lee,&nbsp;Seong-Kyoon Choi,&nbsp;Janbolat Ashim,&nbsp;Wansoo Kim,&nbsp;Su-Min Beak,&nbsp;Jin-Kyu Park,&nbsp;Jee Eun Han,&nbsp;Gil-Jae Cho,&nbsp;Zae Young Ryoo,&nbsp;Jain Jeong,&nbsp;Yong-Ho Lee,&nbsp;Hyohoon Jeong,&nbsp;Wookyung Yu,&nbsp;Song Park","doi":"10.1142/S0192415X2350060X","DOIUrl":"10.1142/S0192415X2350060X","url":null,"abstract":"<p><p>Prostate cancer (PC) is the second leading cause of cancer-related death among men. Treatment of PC becomes difficult after progression because PC that used to be androgen-dependent becomes androgen-independent prostate cancer (AIPC). Veratramine, an alkaloid extracted from the root of the <i>Veratrum</i> genus, has recently been reported to have anticancer effects that work against various cancers; however, its anticancer effects and the underlying mechanism of action in PC remain unknown. We investigated the anticancer effects of veratramine on AIPC using PC3 and DU145 cell lines, as well as a xenograft mouse model. The antitumor effects of veratramine were evaluated using the CCK-8, anchorage-independent colony formation, trans-well, wound healing assays, and flow cytometry in AIPC cell lines. Microarray and proteomics analyses were performed to investigate the differentially expressed genes and proteins induced by veratramine in AIPC cells. A xenograft mouse model was used to confirm the therapeutic response and <i>in vivo</i> efficacy of veratramine. Veratramine dose dependently reduced the proliferation of cancer cells both <i>in vitro</i> and <i>in vivo</i>. Moreover, veratramine treatment effectively suppressed the migration and invasion of PC cells. The immunoblot analysis revealed that veratramine significantly downregulated Cdk4/6 and cyclin D1 via the ATM/ATR and Akt pathways, both of which induce a DNA damage response that eventually leads to G1 phase arrest. In this study, we discovered that veratramine exerted antitumor effects on AIPC cells. We demonstrated that veratramine significantly inhibited the proliferation of cancer cells via G0/G1 phase arrest induced by the ATM/ATR and Akt pathways. These results suggest that veratramine is a promising natural therapeutic agent for AIPC.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 5","pages":"1309-1333"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9858682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the Application of Traditional Chinese Medicine Using Artificial Intelligence: A Review. 人工智能在中药应用中的研究进展
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500490
Sheng Zhang, Wei Wang, Xitian Pi, Zichun He, Hongying Liu

Traditional Chinese medicine (TCM), as one of the crystallizations of Chinese wisdom, emphasizes the balance of Yin and Yang to keep the body healthy. Under the theoretical guidance of a holistic view, the diagnostic process in TCM has characteristics of subjectivity, fuzziness, and complexity. Therefore, realizing standardization and achieving objective quantitative analysis are the bottlenecks of the development of TCM. The emergence of artificial intelligence (AI) technology has brought unprecedented challenges and opportunities to traditional medicine, which is expected to provide objective measurements and improve the clinical efficacy. However, the combination of TCM and AI is still in its infancy and currently faces many challenges. Therefore, this review provides a comprehensive discussion of the existing advances, problems, and prospects of the applications of AI technologies in TCM with the hope of promoting a better understanding of the TCM modernization and intellectualization.

中医作为中国智慧的结晶之一,强调阴阳平衡以保持身体健康。在整体观的理论指导下,中医的诊断过程具有主观性、模糊性和复杂性等特点。因此,实现规范化,实现客观定量分析是中医药发展的瓶颈。人工智能(AI)技术的出现给传统医学带来了前所未有的挑战和机遇,它有望提供客观的测量和提高临床疗效。然而,中医与人工智能的结合仍处于起步阶段,目前面临许多挑战。因此,本文就人工智能技术在中医领域的应用现状、存在的问题及前景进行了综述,以期促进人们对中医现代化和智能化的认识。
{"title":"Advances in the Application of Traditional Chinese Medicine Using Artificial Intelligence: A Review.","authors":"Sheng Zhang,&nbsp;Wei Wang,&nbsp;Xitian Pi,&nbsp;Zichun He,&nbsp;Hongying Liu","doi":"10.1142/S0192415X23500490","DOIUrl":"https://doi.org/10.1142/S0192415X23500490","url":null,"abstract":"<p><p>Traditional Chinese medicine (TCM), as one of the crystallizations of Chinese wisdom, emphasizes the balance of Yin and Yang to keep the body healthy. Under the theoretical guidance of a holistic view, the diagnostic process in TCM has characteristics of subjectivity, fuzziness, and complexity. Therefore, realizing standardization and achieving objective quantitative analysis are the bottlenecks of the development of TCM. The emergence of artificial intelligence (AI) technology has brought unprecedented challenges and opportunities to traditional medicine, which is expected to provide objective measurements and improve the clinical efficacy. However, the combination of TCM and AI is still in its infancy and currently faces many challenges. Therefore, this review provides a comprehensive discussion of the existing advances, problems, and prospects of the applications of AI technologies in TCM with the hope of promoting a better understanding of the TCM modernization and intellectualization.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 5","pages":"1067-1083"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diosgenin Attenuates Myocardial Cell Apoptosis Triggered by Oxidative Stress through Estrogen Receptor to Activate the PI3K/Akt and ERK Axes. 薯蓣皂苷元通过雌激素受体激活PI3K/Akt和ERK轴,减轻氧化应激引发的心肌细胞凋亡。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500556
Michael Yu-Chih Chen, Bruce Chi-Kang Tsai, Wei-Wen Kuo, Chia-Hua Kuo, Yueh-Min Lin, Dennis Jine-Yuan Hsieh, Pei-Ying Pai, Shih-Chieh Liao, Shang-En Huang, Shin-Da Lee, Chih-Yang Huang

Cardiovascular diseases in post-menopausal women are on a rise. Oxidative stress is the main contributing factor to the etiology and pathogenesis of cardiovascular diseases. Diosgenin, a member of steroidal sapogenin, is structurally similar to estrogen and has been shown to have antioxidant effects. Therefore, we aimed to investigate the effects of diosgenin in preventing oxidation-induced cardiomyocyte apoptosis and assessed its potential as a substitute substance for estrogen in post-menopausal women. Apoptotic pathways and mitochondrial membrane potential were measured in H9c2 cardiomyoblast cells and neonatal cardiomyocytes treated with diosgenin for 1[Formula: see text]h prior to hydrogen peroxide (H2O2) stimulation. H2O2-stimulated H9c2 cardiomyoblast cells displayed cytotoxicity and apoptosis via the activation of both Fas-dependent and mitochondria-dependent pathways. Additionally, it led to the instability of the mitochondrial membrane potential. However, the H2O2-induced H9c2 cell apoptosis was rescued by diosgenin through IGF1 survival pathway activation. This led to the recovery of the mitochondrial membrane potential by suppressing the Fas-dependent and mitochondria-dependent apoptosis. Diosgenin also inhibited H2O2-induced cytotoxicity and apoptosis through the estrogen receptor interaction with PI3K/Akt and extracellular regulated protein kinases 1/2 activation in myocardial cells. In this study, we confirmed that diosgenin attenuated H2O2-induced cytotoxicity and apoptosis through estrogen receptors-activated phosphorylation of PI3K/Akt and ERK signaling pathways in myocardial cells via estrogen receptor interaction. All results suggest that H2O2-induced myocardial damage is reduced by diosgenin due to its interaction with estrogen receptors to decrease the damage. Herein, we conclude that diosgenin might be a potential substitute substance for estrogen in post-menopausal women to prevent heart diseases.

绝经后妇女的心血管疾病呈上升趋势。氧化应激是心血管疾病的病因和发病机制的主要影响因素。薯蓣皂苷元是甾体皂苷元的一员,其结构与雌激素相似,并已被证明具有抗氧化作用。因此,我们旨在研究薯蓣皂苷元在预防氧化诱导的心肌细胞凋亡中的作用,并评估其作为绝经后妇女雌激素替代品的潜力。在过氧化氢(H2O2)刺激前,用dioosgenin处理H9c2成心肌细胞和新生儿心肌细胞1 h,测量细胞凋亡途径和线粒体膜电位。h2o2刺激的H9c2成心肌细胞通过fas依赖性和线粒体依赖性途径的激活表现出细胞毒性和凋亡。此外,它导致线粒体膜电位的不稳定。而薯蓣皂苷元通过激活IGF1存活通路,挽救h2o2诱导的H9c2细胞凋亡。这通过抑制fas依赖性和线粒体依赖性的凋亡导致线粒体膜电位的恢复。薯蓣皂苷元还通过雌激素受体与心肌细胞PI3K/Akt和胞外调节蛋白激酶1/2活化的相互作用抑制h2o2诱导的细胞毒性和凋亡。在本研究中,我们证实了薯蓣皂苷元通过雌激素受体相互作用激活心肌细胞中PI3K/Akt和ERK信号通路的磷酸化,从而减弱h2o2诱导的细胞毒性和细胞凋亡。综上所述,薯蓣皂苷元通过与雌激素受体相互作用减轻h2o2引起的心肌损伤。在此,我们得出结论,薯蓣皂苷元可能是绝经后妇女雌激素的潜在替代品,以预防心脏病。
{"title":"Diosgenin Attenuates Myocardial Cell Apoptosis Triggered by Oxidative Stress through Estrogen Receptor to Activate the PI3K/Akt and ERK Axes.","authors":"Michael Yu-Chih Chen,&nbsp;Bruce Chi-Kang Tsai,&nbsp;Wei-Wen Kuo,&nbsp;Chia-Hua Kuo,&nbsp;Yueh-Min Lin,&nbsp;Dennis Jine-Yuan Hsieh,&nbsp;Pei-Ying Pai,&nbsp;Shih-Chieh Liao,&nbsp;Shang-En Huang,&nbsp;Shin-Da Lee,&nbsp;Chih-Yang Huang","doi":"10.1142/S0192415X23500556","DOIUrl":"https://doi.org/10.1142/S0192415X23500556","url":null,"abstract":"<p><p>Cardiovascular diseases in post-menopausal women are on a rise. Oxidative stress is the main contributing factor to the etiology and pathogenesis of cardiovascular diseases. Diosgenin, a member of steroidal sapogenin, is structurally similar to estrogen and has been shown to have antioxidant effects. Therefore, we aimed to investigate the effects of diosgenin in preventing oxidation-induced cardiomyocyte apoptosis and assessed its potential as a substitute substance for estrogen in post-menopausal women. Apoptotic pathways and mitochondrial membrane potential were measured in H9c2 cardiomyoblast cells and neonatal cardiomyocytes treated with diosgenin for 1[Formula: see text]h prior to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) stimulation. H<sub>2</sub>O<sub>2</sub>-stimulated H9c2 cardiomyoblast cells displayed cytotoxicity and apoptosis via the activation of both Fas-dependent and mitochondria-dependent pathways. Additionally, it led to the instability of the mitochondrial membrane potential. However, the H<sub>2</sub>O<sub>2</sub>-induced H9c2 cell apoptosis was rescued by diosgenin through IGF1 survival pathway activation. This led to the recovery of the mitochondrial membrane potential by suppressing the Fas-dependent and mitochondria-dependent apoptosis. Diosgenin also inhibited H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity and apoptosis through the estrogen receptor interaction with PI3K/Akt and extracellular regulated protein kinases 1/2 activation in myocardial cells. In this study, we confirmed that diosgenin attenuated H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity and apoptosis through estrogen receptors-activated phosphorylation of PI3K/Akt and ERK signaling pathways in myocardial cells via estrogen receptor interaction. All results suggest that H<sub>2</sub>O<sub>2</sub>-induced myocardial damage is reduced by diosgenin due to its interaction with estrogen receptors to decrease the damage. Herein, we conclude that diosgenin might be a potential substitute substance for estrogen in post-menopausal women to prevent heart diseases.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 5","pages":"1211-1232"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9864132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Quercetin Inhibits Intrahepatic Cholangiocarcinoma by Inducing Ferroptosis and Inhibiting Invasion via the NF-[Formula: see text]B Pathway. 槲皮素通过NF- B通路诱导铁下垂和抑制侵袭抑制肝内胆管癌。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500337
Yinghui Song, Zhihua Zhang, Qin Chai, He Zheng, Yuchen Qi, Guoyi Xia, Zhangtao Yu, Ranzhiqiang Yang, Junkai Huang, Yuhang Li, Chuang Peng, Bo Jiang, Sulai Liu

Intrahepatic cholangiocarcinoma (ICC) is a rare, highly fatal hepatobiliary malignancy, with very limited treatment options and, consequently, a poor prognosis. Recently, emerging evidence has suggested the potential of quercetin (QE) for use in cancer therapy. The purpose of this study is to investigate whether QE could inhibit ICC. The effects of QE on the proliferation, apoptosis, and invasion of ICC were analyzed in vitro. The inhibitory effect of QE on ICC was also verified in vivo. The RNA sequence was applied to explore the mechanism of QE. Functional verification was also performed after RNA sequencing using activators and inhibitors of nuclear factor-kappa-B (NF-[Formula: see text]B) and ferroptosis. The results showed that QE could inhibit the proliferation and survival of ICC cells, induce the arrest of ICC cells in the G1 phase, promote the apoptosis of ICC cells, and inhibit the invasion of ICC cells. Furthermore, QE could promote ferroptosis in ICC cells by inhibiting the NF-[Formula: see text]B pathway. In conclusion, QE is a new ferroptosis inducer and NF-[Formula: see text]B inhibitor that can not only induce ferroptosis, but also inhibit the invasion of ICC cells, providing a prospective strategy for the treatment of ICC.

肝内胆管癌(ICC)是一种罕见的、高度致命的肝胆恶性肿瘤,治疗选择非常有限,因此预后较差。最近,新出现的证据表明槲皮素(QE)在癌症治疗中的应用潜力。本研究的目的是探讨QE是否可以抑制ICC。分析了QE对体外培养的ICC细胞增殖、凋亡和侵袭的影响。在体内也验证了QE对ICC的抑制作用。利用RNA序列研究QE的作用机制。使用核因子- κ B (NF-[公式:见文本]B)和铁下垂的激活剂和抑制剂进行RNA测序后,也进行了功能验证。结果表明,QE能抑制ICC细胞的增殖和存活,诱导ICC细胞在G1期被阻滞,促进ICC细胞凋亡,抑制ICC细胞的侵袭。此外,QE可通过抑制NF- B通路促进ICC细胞铁下垂。综上所述,QE是一种新的铁下垂诱导剂和NF-[公式:见文]B抑制剂,不仅能诱导铁下垂,还能抑制ICC细胞的侵袭,为ICC的治疗提供了一种有前景的策略。
{"title":"Quercetin Inhibits Intrahepatic Cholangiocarcinoma by Inducing Ferroptosis and Inhibiting Invasion via the NF-[Formula: see text]B Pathway.","authors":"Yinghui Song,&nbsp;Zhihua Zhang,&nbsp;Qin Chai,&nbsp;He Zheng,&nbsp;Yuchen Qi,&nbsp;Guoyi Xia,&nbsp;Zhangtao Yu,&nbsp;Ranzhiqiang Yang,&nbsp;Junkai Huang,&nbsp;Yuhang Li,&nbsp;Chuang Peng,&nbsp;Bo Jiang,&nbsp;Sulai Liu","doi":"10.1142/S0192415X23500337","DOIUrl":"https://doi.org/10.1142/S0192415X23500337","url":null,"abstract":"<p><p>Intrahepatic cholangiocarcinoma (ICC) is a rare, highly fatal hepatobiliary malignancy, with very limited treatment options and, consequently, a poor prognosis. Recently, emerging evidence has suggested the potential of quercetin (QE) for use in cancer therapy. The purpose of this study is to investigate whether QE could inhibit ICC. The effects of QE on the proliferation, apoptosis, and invasion of ICC were analyzed <i>in vitro</i>. The inhibitory effect of QE on ICC was also verified <i>in vivo</i>. The RNA sequence was applied to explore the mechanism of QE. Functional verification was also performed after RNA sequencing using activators and inhibitors of nuclear factor-kappa-B (NF-[Formula: see text]B) and ferroptosis. The results showed that QE could inhibit the proliferation and survival of ICC cells, induce the arrest of ICC cells in the G1 phase, promote the apoptosis of ICC cells, and inhibit the invasion of ICC cells. Furthermore, QE could promote ferroptosis in ICC cells by inhibiting the NF-[Formula: see text]B pathway. In conclusion, QE is a new ferroptosis inducer and NF-[Formula: see text]B inhibitor that can not only induce ferroptosis, but also inhibit the invasion of ICC cells, providing a prospective strategy for the treatment of ICC.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 3","pages":"701-721"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9874919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amelioration of Lung Fibrosis by Total Flavonoids of Astragalus via Inflammatory Modulation and Epithelium Regeneration. 黄芪总黄酮通过炎症调节和上皮再生改善肺纤维化。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500192
Chen-Guang Yang, Xue-Li Mao, Jun-Fei Wu, Xiang An, Jia-Jia Cao, Xiao-Yu Zhang, Min Li, Fang-Fang Zhang

Idiopathic Pulmonary Fibrosis (IPF) is identifiable by the excessive increase of mesenchyme paired with the loss of epithelium. Total flavonoids of Astragalus (TFA), the main biologically active ingredient of the traditional Chinese medicine, Astragalus membranaceus (Huangqi), shows outstanding effects on treating pulmonary disorders, including COVID-19-associated pulmonary dysfunctions. This study was designed to evaluate the efficacy of TFA on treating pulmonary fibrosis and the possible mechanisms behind these effects. A549 cells were treated with TGF-[Formula: see text]1 and TFA to observe the potential effects of TFA on regulating alveolar epithelial cell proliferation, TGF-[Formula: see text]1-induced EMT, and the underlying mechanisms in vitro. Then, mouse pulmonary fibrosis was induced with a single intra-tracheal injection of bleomycin, and TFA was administrated by i.p. injection. Lung fibrosis was evaluated through histological and molecular analyses, and the possible mechanisms were explored using immunological methods. The results demonstrated that TFA could promote cell proliferation but inhibit TGF-[Formula: see text]1-induced EMT on A549 cells. TFA attenuated BLM-induced pulmonary fibrosis in mice by modulating inflammatory infiltration and M2 macrophage polarization; it furthermore modulated EMT through regulating the TGF-[Formula: see text]1/Smad pathway. In addition, TFA augmented the expression of the Wnt7b protein, which plays an important role in alveolar epithelium reparation. In conclusion, TFA alleviated bleomycin-induced mouse lung fibrosis by preventing the fibrotic response and increasing epithelium regeneration.

特发性肺纤维化(IPF)可通过间质过度增加和上皮细胞的缺失来识别。黄芪总黄酮(Total flavonoids of Astragalus, TFA)是中药黄芪的主要生物活性成分,在治疗肺部疾病,包括与covid -19相关的肺功能障碍方面表现出突出的效果。本研究旨在评估TFA治疗肺纤维化的疗效及其可能的机制。采用TGF-[公式:见文]1和TFA处理A549细胞,观察TFA对肺泡上皮细胞增殖、TGF-[公式:见文]1诱导的EMT的潜在调节作用及其体外机制。然后气管内单次注射博来霉素诱导小鼠肺纤维化,TFA通过腹腔注射给药。通过组织学和分子分析评估肺纤维化,并利用免疫学方法探讨可能的机制。结果表明,TFA能促进细胞增殖,抑制TGF-[公式:见文]1诱导的A549细胞EMT。TFA通过调节炎症浸润和M2巨噬细胞极化减轻blm诱导的小鼠肺纤维化;进而通过调节TGF-[公式:见文]1/Smad通路调节EMT。此外,TFA增加了在肺泡上皮修复中起重要作用的Wnt7b蛋白的表达。综上所述,TFA通过抑制纤维化反应和促进上皮再生来减轻博来霉素诱导的小鼠肺纤维化。
{"title":"Amelioration of Lung Fibrosis by Total Flavonoids of Astragalus via Inflammatory Modulation and Epithelium Regeneration.","authors":"Chen-Guang Yang,&nbsp;Xue-Li Mao,&nbsp;Jun-Fei Wu,&nbsp;Xiang An,&nbsp;Jia-Jia Cao,&nbsp;Xiao-Yu Zhang,&nbsp;Min Li,&nbsp;Fang-Fang Zhang","doi":"10.1142/S0192415X23500192","DOIUrl":"https://doi.org/10.1142/S0192415X23500192","url":null,"abstract":"<p><p>Idiopathic Pulmonary Fibrosis (IPF) is identifiable by the excessive increase of mesenchyme paired with the loss of epithelium. Total flavonoids of Astragalus (TFA), the main biologically active ingredient of the traditional Chinese medicine, <i>Astragalus membranaceus</i> (Huangqi), shows outstanding effects on treating pulmonary disorders, including COVID-19-associated pulmonary dysfunctions. This study was designed to evaluate the efficacy of TFA on treating pulmonary fibrosis and the possible mechanisms behind these effects. A549 cells were treated with TGF-[Formula: see text]1 and TFA to observe the potential effects of TFA on regulating alveolar epithelial cell proliferation, TGF-[Formula: see text]1-induced EMT, and the underlying mechanisms <i>in vitro</i>. Then, mouse pulmonary fibrosis was induced with a single intra-tracheal injection of bleomycin, and TFA was administrated by i.p. injection. Lung fibrosis was evaluated through histological and molecular analyses, and the possible mechanisms were explored using immunological methods. The results demonstrated that TFA could promote cell proliferation but inhibit TGF-[Formula: see text]1-induced EMT on A549 cells. TFA attenuated BLM-induced pulmonary fibrosis in mice by modulating inflammatory infiltration and M2 macrophage polarization; it furthermore modulated EMT through regulating the TGF-[Formula: see text]1/Smad pathway. In addition, TFA augmented the expression of the Wnt7b protein, which plays an important role in alveolar epithelium reparation. In conclusion, TFA alleviated bleomycin-induced mouse lung fibrosis by preventing the fibrotic response and increasing epithelium regeneration.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 2","pages":"373-389"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9579331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capsaicin Reduces Cancer Stemness and Inhibits Metastasis by Downregulating SOX2 and EZH2 in Osteosarcoma. 辣椒素通过下调骨肉瘤中SOX2和EZH2的表达降低肿瘤的干性并抑制转移。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500489
Zhi-Yu Chen, Huan-Huan Huang, Qiao-Chu Li, Fang-Biao Zhan, Ling-Bang Wang, Tao He, Chao-Hua Yang, Yang Wang, Yuan Zhang, Zheng-Xue Quan

Metastasis of osteosarcoma is an important adverse factor affecting patients' survival, and cancer stemness is the crucial cause of distant metastasis. Capsaicin, the main component of pepper, has been proven in our previous work to inhibit osteosarcoma proliferation and enhance its drug sensitivity to cisplatin at low concentrations. This study aims to further explore the anti-osteosarcoma effect of capsaicin at low concentrations (100[Formula: see text][Formula: see text]M, 24[Formula: see text]h) on stemness and metastasis. The stemness of human osteosarcoma (HOS) cells was decreased significantly by capsaicin treatment. Additionally, the capsaicin treatment's inhibition of cancer stem cells (CSCs) was dose-dependent on both sphere formation and sphere size. Meanwhile, capsaicin inhibited invasion and migration, which might be associated with 25 metastasis-related genes. SOX2 and EZH2 were the most two relevant stemness factors for capsaicin's dose-dependent inhibition of osteosarcoma. The mRNAsi score of HOS stemness inhibited by capsaicin was strongly correlated with most metastasis-related genes of osteosarcoma. Capsaicin downregulated six metastasis-promoting genes and up-regulated three metastasis-inhibiting genes, which significantly affected the overall survival and/or disease-free survival of patients. In addition, the CSC re-adhesion scratch assay demonstrated that capsaicin inhibited the migration ability of osteosarcoma by inhibiting its stemness. Overall, capsaicin exerts a significant inhibitory effect on the stemness expression and metastatic ability of osteosarcoma. Moreover, it can inhibit the migratory ability of osteosarcoma by suppressing its stemness via downregulating SOX2 and EZH2. Therefore, capsaicin is expected to be a potential drug against osteosarcoma metastasis due to its ability to inhibit cancer stemness.

骨肉瘤的转移是影响患者生存的重要不利因素,而肿瘤的干细胞性是发生骨肉瘤远处转移的重要原因。辣椒素是辣椒的主要成分,在我们之前的研究中已经证实,在低浓度下,辣椒素可以抑制骨肉瘤的增殖并增强其对顺铂的药物敏感性。本研究旨在进一步探讨低浓度辣椒素(100[公式:见文]M, 24[公式:见文]h)对骨肉瘤干性和转移的影响。辣椒素能显著降低人骨肉瘤(HOS)细胞的干性。此外,辣椒素治疗对癌症干细胞(CSCs)的抑制作用与球的形成和球的大小都有剂量依赖性。同时,辣椒素抑制肿瘤的侵袭和迁移,这可能与25个转移相关基因有关。SOX2和EZH2是辣椒素剂量依赖性骨肉瘤抑制最相关的两个干性因子。辣椒素抑制HOS干性的mRNAsi评分与骨肉瘤大多数转移相关基因密切相关。辣椒素下调6个促进转移的基因,上调3个抑制转移的基因,显著影响患者的总生存期和/或无病生存期。此外,CSC再粘附划痕实验表明,辣椒素通过抑制骨肉瘤的干性来抑制骨肉瘤的迁移能力。综上所述,辣椒素对骨肉瘤的干性表达和转移能力有显著的抑制作用。此外,它可以通过下调SOX2和EZH2来抑制骨肉瘤的干性,从而抑制骨肉瘤的迁移能力。因此,辣椒素具有抑制肿瘤发生的作用,有望成为治疗骨肉瘤转移的潜在药物。
{"title":"Capsaicin Reduces Cancer Stemness and Inhibits Metastasis by Downregulating <i>SOX2</i> and <i>EZH2</i> in Osteosarcoma.","authors":"Zhi-Yu Chen,&nbsp;Huan-Huan Huang,&nbsp;Qiao-Chu Li,&nbsp;Fang-Biao Zhan,&nbsp;Ling-Bang Wang,&nbsp;Tao He,&nbsp;Chao-Hua Yang,&nbsp;Yang Wang,&nbsp;Yuan Zhang,&nbsp;Zheng-Xue Quan","doi":"10.1142/S0192415X23500489","DOIUrl":"https://doi.org/10.1142/S0192415X23500489","url":null,"abstract":"<p><p>Metastasis of osteosarcoma is an important adverse factor affecting patients' survival, and cancer stemness is the crucial cause of distant metastasis. Capsaicin, the main component of pepper, has been proven in our previous work to inhibit osteosarcoma proliferation and enhance its drug sensitivity to cisplatin at low concentrations. This study aims to further explore the anti-osteosarcoma effect of capsaicin at low concentrations (100[Formula: see text][Formula: see text]M, 24[Formula: see text]h) on stemness and metastasis. The stemness of human osteosarcoma (HOS) cells was decreased significantly by capsaicin treatment. Additionally, the capsaicin treatment's inhibition of cancer stem cells (CSCs) was dose-dependent on both sphere formation and sphere size. Meanwhile, capsaicin inhibited invasion and migration, which might be associated with 25 metastasis-related genes. <i>SOX2</i> and <i>EZH2</i> were the most two relevant stemness factors for capsaicin's dose-dependent inhibition of osteosarcoma. The mRNAsi score of HOS stemness inhibited by capsaicin was strongly correlated with most metastasis-related genes of osteosarcoma. Capsaicin downregulated six metastasis-promoting genes and up-regulated three metastasis-inhibiting genes, which significantly affected the overall survival and/or disease-free survival of patients. In addition, the CSC re-adhesion scratch assay demonstrated that capsaicin inhibited the migration ability of osteosarcoma by inhibiting its stemness. Overall, capsaicin exerts a significant inhibitory effect on the stemness expression and metastatic ability of osteosarcoma. Moreover, it can inhibit the migratory ability of osteosarcoma by suppressing its stemness via downregulating <i>SOX2</i> and <i>EZH2</i>. Therefore, capsaicin is expected to be a potential drug against osteosarcoma metastasis due to its ability to inhibit cancer stemness.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 4","pages":"1041-1066"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9641287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Research Progress of Chinese Medicine in the Treatment of Myocardial Ischemia-Reperfusion Injury. 中药治疗心肌缺血再灌注损伤的研究进展。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500015
Li Dong, Zhijie Shen, Hao Chi, Yingjie Wang, Zhaofeng Shi, Hongjun Fang, Yanling Yang, Jingfeng Rong

Vascular recanalization is the essential procedure in which severe coronary artery stenosis is diagnosed. However, the blood flow recovery associated with this procedure may cause myocardial ischemia-reperfusion injury (MIRI), which aggravates heart failure. Unfortunately, the mechanism of MIRI has historically been poorly understood. As we now know, calcium overloading, oxidative stress, mitochondrial dysfunction, inflammatory responses, and ferroptosis take part in the process of MIRI. Modern medicine has shown through clinical studies its own limited effects in the case of MIRI, whereas Chinese traditional medicine demonstrates a strong vitality. Multiple-target effects, such as anti-inflammatory, anti-oxidant, and cardio-protection effects, are central to this vitality. In our clinic center, Yixin formula is commonly used in patients with MIRI. This formula contains Astragalus, Ligusticum Wallichii, Salvia, Rhodiola Rosea, Radix Angelicae Sinensis, Cyperus Rotundus, and Cassia Twig. Its effects include warming yang energy, activating blood circulation, and eliminating blood stasis. In our previous laboratory studies, we have proved that it can reduce MIRI and oxidative stress injury in rats suffering from ischemia myocardiopathy. It can also inhibit apoptosis and protect myocardium. In this paper, we review the research of Yixin formula and other related herbal medicines in MIRI therapy.

血管再通术是诊断严重冠状动脉狭窄的必要手术。然而,与此过程相关的血流恢复可能导致心肌缺血-再灌注损伤(MIRI),从而加重心力衰竭。不幸的是,历史上人们对MIRI的机制知之甚少。我们现在知道,钙超载、氧化应激、线粒体功能障碍、炎症反应和铁下垂参与了MIRI的过程。现代医学在治疗MIRI方面的临床研究表明其疗效有限,而中医则显示出强大的生命力。多目标作用,如抗炎、抗氧化和心脏保护作用,是这种活力的核心。在我们的临床中心,益心方是MIRI患者常用的治疗方法。本配方含黄芪、川芎、丹参、红景天、当归、香附、决明子。它的作用包括暖阳、活血、化瘀。在我们之前的实验室研究中,我们已经证明它可以减少缺血心肌病大鼠的MIRI和氧化应激损伤。还能抑制细胞凋亡,保护心肌。本文就益心方及相关中药在MIRI治疗中的研究进展进行综述。
{"title":"Research Progress of Chinese Medicine in the Treatment of Myocardial Ischemia-Reperfusion Injury.","authors":"Li Dong,&nbsp;Zhijie Shen,&nbsp;Hao Chi,&nbsp;Yingjie Wang,&nbsp;Zhaofeng Shi,&nbsp;Hongjun Fang,&nbsp;Yanling Yang,&nbsp;Jingfeng Rong","doi":"10.1142/S0192415X23500015","DOIUrl":"https://doi.org/10.1142/S0192415X23500015","url":null,"abstract":"<p><p>Vascular recanalization is the essential procedure in which severe coronary artery stenosis is diagnosed. However, the blood flow recovery associated with this procedure may cause myocardial ischemia-reperfusion injury (MIRI), which aggravates heart failure. Unfortunately, the mechanism of MIRI has historically been poorly understood. As we now know, calcium overloading, oxidative stress, mitochondrial dysfunction, inflammatory responses, and ferroptosis take part in the process of MIRI. Modern medicine has shown through clinical studies its own limited effects in the case of MIRI, whereas Chinese traditional medicine demonstrates a strong vitality. Multiple-target effects, such as anti-inflammatory, anti-oxidant, and cardio-protection effects, are central to this vitality. In our clinic center, Yixin formula is commonly used in patients with MIRI. This formula contains <i>Astragalus, Ligusticum Wallichii, Salvia, Rhodiola Rosea, Radix Angelicae Sinensis, Cyperus Rotundus</i>, and <i>Cassia Twig</i>. Its effects include warming yang energy, activating blood circulation, and eliminating blood stasis. In our previous laboratory studies, we have proved that it can reduce MIRI and oxidative stress injury in rats suffering from ischemia myocardiopathy. It can also inhibit apoptosis and protect myocardium. In this paper, we review the research of Yixin formula and other related herbal medicines in MIRI therapy.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 1","pages":"1-17"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10637129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Gardenia jasminoides Extract GJ-4 Alleviates Memory Deficiency of Vascular Dementia in Rats through PERK-Mediated Endoplasmic Reticulum Stress Pathway. 栀子提取物GJ-4通过perk介导的内质网应激途径缓解血管性痴呆大鼠记忆缺陷。
IF 5.7 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2023-01-01 DOI: 10.1142/S0192415X23500040
Fang-Yu Yuan, Cheng Ju, Cai-Xia Zang, Hui Liu, Mei-Yu Shang, Jing-Wen Ning, Yang Yang, Jing-Wei Ma, Gen Li, Yang Yu, Xin-Sheng Yao, Xiu-Qi Bao, Dan Zhang

Endoplasmic reticulum stress (ERS) is involved in the pathological process of vascular dementia (VD). GJ-4 is extracted from Gardenia jasminoides J. Ellis and has been reported to have protective roles in ischemia-related brain damage. However, the role of GJ-4 in ERS has not been elucidated. We established a VD rat model through bilateral common carotid arteries occlusion (2-VO). The rats were intragastrically administrated with GJ-4 (10, 25, and 50[Formula: see text]mg/kg) and nimodipine (10[Formula: see text]mg/kg). Data from a Morris water maze test showed that GJ-4 could significantly alleviate learning and memory deficits in VD rats. Nissl and cleaved caspase-3 staining revealed that GJ-4 can inhibit apoptosis and thus exert a protective role in the brain of 2-VO rats. Western blot results suggested that GJ-4 significantly reduced ERS-related protein expression and inhibited apoptosis through suppression of the PERK/eIF2[Formula: see text]/ATF4/CHOP signaling pathway. For in vitro studies, the oxygen-glucose deprivation (OGD) SH-SY5Y model was employed. Western blot and Hoechst 33342/PI double staining were utilized to explore the effects of crocetin, the main active metabolite of GJ-4. Like GJ-4 in vivo, crocetin in vitro also decreased ERS-related protein expression and inhibited the activation of the PERK/eIF2[Formula: see text]/ATF4/CHOP signaling pathway. Thus, crocetin exerted similar protective roles on OGD challenged SH-SY5Y cells in vitro. In summary, GJ-4 and crocetin reduce the ERS in the brain of VD rats and SY5Y cells subjected to OGD and inhibit neuronal apoptosis through suppression of the PERK/eIF2[Formula: see text]/ATF4/CHOP pathway, suggesting that GJ-4 may be useful for the treatment of VD.

内质网应激(ERS)参与血管性痴呆(VD)的病理过程。GJ-4是从栀子花中提取的,据报道在缺血性脑损伤中具有保护作用。然而,GJ-4在ERS中的作用尚未阐明。我们通过双侧颈总动脉闭塞(2-VO)建立VD大鼠模型。大鼠灌胃GJ-4(10、25、50[配方:见文]mg/kg)和尼莫地平(10[配方:见文]mg/kg)。Morris水迷宫实验数据显示,GJ-4能显著缓解VD大鼠的学习记忆缺陷。Nissl染色和cleaved caspase-3染色显示GJ-4可以抑制2-VO大鼠脑细胞凋亡,从而发挥保护作用。Western blot结果显示,GJ-4通过抑制PERK/eIF2[公式:见文]/ATF4/CHOP信号通路,显著降低ers相关蛋白表达,抑制细胞凋亡。体外实验采用氧葡萄糖剥夺(OGD) SH-SY5Y模型。采用Western blot和Hoechst 33342/PI双染色法观察GJ-4主要活性代谢物西红花苷的作用。与体内的GJ-4一样,红花素在体外也能降低ers相关蛋白的表达,抑制PERK/eIF2[公式:见文]/ATF4/CHOP信号通路的激活。因此,红花素对体外OGD激发的SH-SY5Y细胞具有类似的保护作用。综上所述,GJ-4和crocetin通过抑制PERK/eIF2[公式:见文]/ATF4/CHOP通路,降低VD大鼠脑内ERS和OGD后SY5Y细胞,抑制神经元凋亡,提示GJ-4可能对VD的治疗有用。
{"title":"<i>Gardenia jasminoides</i> Extract GJ-4 Alleviates Memory Deficiency of Vascular Dementia in Rats through PERK-Mediated Endoplasmic Reticulum Stress Pathway.","authors":"Fang-Yu Yuan,&nbsp;Cheng Ju,&nbsp;Cai-Xia Zang,&nbsp;Hui Liu,&nbsp;Mei-Yu Shang,&nbsp;Jing-Wen Ning,&nbsp;Yang Yang,&nbsp;Jing-Wei Ma,&nbsp;Gen Li,&nbsp;Yang Yu,&nbsp;Xin-Sheng Yao,&nbsp;Xiu-Qi Bao,&nbsp;Dan Zhang","doi":"10.1142/S0192415X23500040","DOIUrl":"https://doi.org/10.1142/S0192415X23500040","url":null,"abstract":"<p><p>Endoplasmic reticulum stress (ERS) is involved in the pathological process of vascular dementia (VD). GJ-4 is extracted from <i>Gardenia jasminoides</i> J. Ellis and has been reported to have protective roles in ischemia-related brain damage. However, the role of GJ-4 in ERS has not been elucidated. We established a VD rat model through bilateral common carotid arteries occlusion (2-VO). The rats were intragastrically administrated with GJ-4 (10, 25, and 50[Formula: see text]mg/kg) and nimodipine (10[Formula: see text]mg/kg). Data from a Morris water maze test showed that GJ-4 could significantly alleviate learning and memory deficits in VD rats. Nissl and cleaved caspase-3 staining revealed that GJ-4 can inhibit apoptosis and thus exert a protective role in the brain of 2-VO rats. Western blot results suggested that GJ-4 significantly reduced ERS-related protein expression and inhibited apoptosis through suppression of the PERK/eIF2[Formula: see text]/ATF4/CHOP signaling pathway. For <i>in vitro</i> studies, the oxygen-glucose deprivation (OGD) SH-SY5Y model was employed. Western blot and Hoechst 33342/PI double staining were utilized to explore the effects of crocetin, the main active metabolite of GJ-4. Like GJ-4 <i>in vivo</i>, crocetin <i>in vitro</i> also decreased ERS-related protein expression and inhibited the activation of the PERK/eIF2[Formula: see text]/ATF4/CHOP signaling pathway. Thus, crocetin exerted similar protective roles on OGD challenged SH-SY5Y cells <i>in vitro</i>. In summary, GJ-4 and crocetin reduce the ERS in the brain of VD rats and SY5Y cells subjected to OGD and inhibit neuronal apoptosis through suppression of the PERK/eIF2[Formula: see text]/ATF4/CHOP pathway, suggesting that GJ-4 may be useful for the treatment of VD.</p>","PeriodicalId":50814,"journal":{"name":"American Journal of Chinese Medicine","volume":"51 1","pages":"53-72"},"PeriodicalIF":5.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10691310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Chinese Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1